The clinical quality indicators for haematology are:
This is the clinical quality indicator for the proportion of patients alive one year after allogeneic stem cell transplantation.
Transplant survival at one year is a measure of:
- the efficacy of the transplant regimen and the quality of clinical care, and
- patient selection prior to transplantation.
It is a recognised measure of the stem cell transplant outcome which takes into account failure of therapy through treatment-related complications and original haematological malignancy.
We aim to achieve a one year survival in excess of 60%, which would place us in the top 10% of transplant centres internationally.